Trial record 1 of 1 for:    NCT01584076
Previous Study | Return to List | Next Study

Treatment of Residual Amblyopia With Donepezil

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01584076
Recruitment Status : Recruiting
First Posted : April 24, 2012
Last Update Posted : March 23, 2018
Information provided by (Responsible Party):
Carolyn Wu, Boston Children’s Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2020
  Estimated Study Completion Date : December 2020